Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly. However, early detection and advanced treatments can significantly improve survival rates. Researchers at Kaunas University of Technology (KTU) are contributing to the development of a non-invasive melanoma treatment, using light and special dyes.
Health Professionals
Lipson Discusses Treatment Selection, Toxicity, and Duration of IO in Melanoma
During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in metastatic melanoma and when to stop therapy.
Observation Is a Reasonable Alternative to Adjuvant PD-1 Blockade in Stage IIB/IIIC Melanoma
Tara C. Mitchell, MD, discusses considerations and lingering questions regarding pre- and post-operative management strategies in stage IIB/IIIC melanoma.
Melanoma Patients’ Given New Hope With Ground-Breaking Clinical Trial | 10 News First
Melanoma patients with some of the worst diagnoses having seen the disease spread to their brains are tonight being given a major boost of hope, all thanks to a ground-breaking clinical trial.